In the knowledge society of 21st century, intellectual property rights (IPRs) are real assets and much more valuable and important than are materialistic assets like house, motor car, and so on. Patents are given for inventions which fulfill few important conditions, such as novelty, inventiveness, industrial application, and written description. Significantly, biotechnological invention involves monopoly over life or living beings or living processes, and morally and ethically these are considered to involve tinkering with life or nature. However, today, biotechnological inventions are patentable because of their benefits and utility to the industry. This article is a humble attempt to examine international and national law and judicial decisions relating to patents and biotechnological inventions from a theoretical perspective.
INTRODUCTION
In the knowledge society of the 21st century, intellectual property rights (IPRs) are real assets and much more valuable and important than are materialistic assets like house, motor car, and so forth. Even the United Nations has supported it that "in today's knowledge based society, intellectual property is a tool for promoting wealth creation as well as social, economic and cultural development." 1 According to World Intellectual Property Organization (WIPO) definition, IPRs refer to creations of the mind, inventions, literary, artistic work, symbols, names, images, and designs used in commerce. Broadly, IPRs could be divided into two parts: Firstly, relating to industrial property which involves patents, industrial designs, and trademarks having industrial applications; 2 The word "patent" has originated from the Latin word "patere," which means to "lay open," that is, make available for public inspection. Patent is an exclusive right to use or exercise an invention, granted to a person by the State for a limited period in consideration of the disclosure of the invention. It excludes others from doing certain acts in relation to that invention for a specific period of time. Further, like the owner of patent or patentee, assignee and licensee (to whom right(s) are transferred by patentee) could also do some acts and exercise certain rights in relation to such invention.
PATeNTINg BIOTeChNOLOgICAL INveNTION
Biotechnology is a study relating to the practical application of living beings in different fields or relating to living organisms in the industrial utilization. Biotechnological invention involves monopoly over life or living beings or living processes, and morally and ethically these are considered to involve tinkering with life or nature. Significantly, patenting life was never considered possible because life is a creation of nature and human beings cannot get exclusive right over it. 3 However, developments in science and technology, especially in biotechnology, have created nonnatural living beings and the application, utility, and benefits of such nonnatural living beings or nonnatural living processes forced our system to broaden the base of patent law, and hence biotechnological inventions became patentable. Therefore, natural life is a creation of nature and hence nonpatentable, whereas nonnatural life is creation of man which involves the application of human ingenuity or intelligence to natural living beings and hence patentable.
Significantly 24 i.e., the patent is for a vaccine or the antibodies generated against the virus. However, it is different from the Ebola Zaire (EBOV) virus, which is the cause of the 2014 outbreak.
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The US government's latest Ebola patent application has been rejected by the USPTO based on different problems. That means research on Ebola going on around the world will continue. on a process of producing proteins through in vitro propagation of hepatitis C virus in a nonnatural and biotechnological way.
Patenting Biotechnological Invention: Indian Perspective
Section 3 of the Indian Patent Act 1970 mentions nonpatentable inventions, such as an invention which is frivolous or which claims anything obviously contrary to well-established natural laws, intended use or exploitation of which would be contrary to public order or morality or which causes serious prejudice to human, animal, or plant life or health or to the environment. 31 This means that only those biotechnological inventions are patentable in India which are useful to society, hence any invention which is harmful to law of nature or human, animal, or plant life or health or to the environment is nonpatentable in India. In Dimminaco AG vs Controller of Patents and Design, 32 the Kolkata High Court held that the process of preparing a commodity which contains a living substance is also covered under the purview of manufacture. Accordingly, process patent was issued to the applicant by the patent office.
It is important to mention here that there are not yet much judicial decisions in India about patenting of biotechnological inventions.
CONCLUSION AND SUggeSTIONS
After critical analysis, it is concluded that patent is an exclusive right granted by the state for an invention, which is a product or a process. However, such invention must involve inventiveness and must be useful to society.
In other words, it must either provide a new way of doing something or offers a new technical solution to a problem. However, to get a patent, technical information about the invention must be disclosed to the public in a patent application. On the whole, patents are incentives to invent and innovate things which are new and useful. 33 Undoubtedly, the main advantage of patent is that it is an exclusive right provided to a patent holder, but it has certain drawbacks also, such as for 20 years no one except the patentee can use any part of the patent product or process. That means in patent process the use of one step by someone else may amount to infringement of patent. Another drawback of patent is price inflation; i.e., as patents are an exclusive right that creates a temporary monopoly, the patent holder can set a market price higher than the competitive price.
Further, there are other drawbacks: After the expiry of exclusive patent period (20 years), any other entity can freely use the invention without any permission from the patentee; applying for patent can be a very lengthy, timeconsuming process; cost of patent filing may be higher than the actual financial gains; and patentee must defend its patent if need be and lastly, taking action against infringement is costly. 34 Despite these drawbacks, patent is considered as strong protection to the inventor. Initially plants, animals, and human beings were kept out of the purview of patent law. However, toward the end of 20th century a new development was seen in patent laws whereby a new trend started under which biotechnological inventions (product and process) could also be patented.
Today, biotechnology is a driving force of modern world, and patent law has reached unprecedented and unforeseen destination as nonnatural lives, or nonnatural living being, and nonnatural processes are patentable. The inventions of biotechnology, which involve addition of human intelligence to the natural processes in producing nonnatural and genetically modified living beings, range from nonnatural microorganisms like bacteria, plasmid, nonnatural plant, nonnatural animal, and nonnatural human genetic material which are undoubtedly patentable in the present scenario. However, in this regard, the decision of the US Supreme Court in 2013 in Association for Molecular Pathology et al vs Myriad Genetics Inc. et al 35 is worth mentioning. It held that "genes and the information they encode are not patentable," as these are not nonnatural genetic material. New guidelines issued by the USPTO made Ebola Virus a nonpatentable invention as it is a natural product. Besides, biotechnological process could also be patented. Today, due to population explosion and other reasons, there is a need of having food and health services at cheaper rates. The solution has been provided by developments in biotechnology. Now biotechnology has become a challenging technique for established industries. Crops may be genetically manipulated to improve their commercial quality and to make them resistant to insects, diseases, or herbicides. Similarly, animal stock can be improved. Also human genetic material could be modified to grow organs for transplantation into humans, to cope with the shortage of natural product. Similarly, stem cell research could do commendable work in the treatment of various diseases, such as osteoporoses, heart attack, diabetes, hepatitis, burn, and degeneration conditions, such as muscular dystrophy, Alzheimer, or Parkinson's disease. Further, embryonic stem cell (eSC) research could provide life to a number of couples. Regarding human cloning and human being, certain countries like the United States and European countries have made it legally nonpatentable. Position is also same under section 3 of Indian Patent Act 1970. Therefore, careful use of patent law holds a significant promise in several areas for the entire humankind.
